2025 ISAKOS Congress in Munich, Germany

ISAKOS 2025 Congress Faculty

 

Olufemi R. Ayeni, MD, PhD, MSc, FRCSC

McMaster University
Hamilton, ON CANADA

Dr. Ayeni is a Professor and Academic Division Head of Orthopaedic Surgery at McMaster University, Canada. He is also an Adjunct Professor in the Department of Health Research Methodology, Evidence and Impact and Medical Director for the Hamilton Tiger Cats (Canadian Football League) and Forge FC (Canadian Premier League). Dr. Ayeni has been named a Tier 2 Canada Research Chair in Joint Preservation Surgery (2022-2027) by the Candian Institutes of Health Research and a University Scholar (2022-2026) at McMaster University. He has published over 400 academic publications in sports medicine and related research, as well as edited several textbooks. Dr. Ayeni is the Co-Chair for the International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine Scientific Committee (2023) and Research Committee Chair for the International Society for Hip Arthroscopy (2021). Recently, he completed roles as Deputy Editor in Chief for the journal of Knee Surgery Sports Traumatology and Arthroscopy (KSSTA) and Scientific Editor for the Canadian Orthopaedic Association Bulletin. His clinical practice and research focuses on minimally invasive orthopaedic interventions that treat joint injuries with the aim to prevent degenerative joint disease.

Sun 06/08
10:00 - 10:45
Room 14c Morning Scientific Session
Symposium
Extra Articular Impingement Syndrome
Faculty
Mon 06/09
15:45 - 16:30
Room 14a Afternoon Scientific Session II
Symposium
JISAKOS: Tips for Successful Writing and Publishing
Chair
Tue 06/10
13:45 - 14:30
General Session - Auditorium Afternoon Scientific Session I
Symposium
The JISAKOS ‘Excellence in Authorship’ Global Cohort Program Awards
Chair

Disclosures

Speaker for Stryker
Board of Directors member for Canadian Orthopaedic Association, International Society for Hip Arthroscopy, International Society of Arthroscopy, Knee Surgery, and Orthopaedic Sports Medicine

All relevant financial disclosures have been mitigated.